The shifting landscape of hypertension in China (2002-2019): key epidemiological insights to catalyze precision cardiovascular protection and universal health coverage.
{"title":"The shifting landscape of hypertension in China (2002-2019): key epidemiological insights to catalyze precision cardiovascular protection and universal health coverage.","authors":"Zilin Zhao, Fei Xu, Hejia Wan","doi":"10.1080/08037051.2025.2552725","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":"34 1","pages":"2552725"},"PeriodicalIF":2.3000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Pressure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08037051.2025.2552725","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/29 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Blood PressureMedicine-Cardiology and Cardiovascular Medicine
CiteScore
3.20
自引率
5.60%
发文量
41
期刊介绍:
For outstanding coverage of the latest advances in hypertension research, turn to Blood Pressure, a primary source for authoritative and timely information on all aspects of hypertension research and management.
Features include:
• Physiology and pathophysiology of blood pressure regulation
• Primary and secondary hypertension
• Cerebrovascular and cardiovascular complications of hypertension
• Detection, treatment and follow-up of hypertension
• Non pharmacological and pharmacological management
• Large outcome trials in hypertension.